1. Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation
   WAN-RONG YI et al, 2016 CrossRef
2. Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes
   Wenchuan Leng et al, 2017, EBioMedicine CrossRef
3. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3
   Xiaoyan Fan et al, 2018, IJMS CrossRef
4. ASV-ID, a Proteogenomic Workflow to Predict Candidate Protein Isoforms based on Transcript Evidence
   Seul-Ki Jeong et al, 2018, J. Proteome Res. CrossRef
5. IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
   Elisa Bergaggio et al, 2019, Blood CrossRef
6. Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
   Elisa Bergaggio et al, 2019, Cancers CrossRef
7. Emerging Anti-cancer Targets in Mitochondria
   Petr Ježek et al, 2014 CrossRef
8. Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts.
   Francesca Ricci et al, 2019, Ther Adv Med Oncol CrossRef
9. Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer
   Wen-Liang Li et al, 2014, Gene CrossRef
10. Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect
    Yanglei Jia et al, 2015, Cancer Med CrossRef
11. Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7
    Dandan Wu, 2016, Tumor Biol. CrossRef
12. A six-gene prognostic model predicts overall survival in bladder cancer patients
    Liwei Wang et al, 2019, Cancer Cell Int CrossRef
13. A new functional IDH2 genetic variant is associated with the risk of lung cancer.
    Jiangjiang Li et al, 2017, Mol Carcinog CrossRef
14. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
    Abrar I Aljohani et al, 2020, Breast Cancer Res Treat CrossRef
15. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Feng Shi et al, 2020, Mol Metab CrossRef
16. AMPKα1 regulates Idh2 transcription through H2B O-GlcNAcylation during brown adipogenesis
    Yuxin Cao et al, 2020 CrossRef
17. Metabolic implications of non-Electrogenic ATP/ADP exchange in Cancer cells: A mechanistic basis for the Warburg effect
    John J. Lemasters, 2021, Biochimica et Biophysica Acta (BBA) - Bioenergetics CrossRef
18. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
    Georgina D. Barnabas et al, 2021, Cancer Res CrossRef
19. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer
    Shuang Qiao et al, 2021, Oncogene CrossRef
20. Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
    Sigurdur Trausti Karvelsson et al, 2021, npj Syst Biol Appl CrossRef
21. IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review)
    Ya Gong et al, 2022, Oncol Lett CrossRef
22. Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer
    Xu Wang et al, 2022, Cancer Cell Int CrossRef
23. Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance
    Qiwei He et al, 2022, Cancers CrossRef
24. The relative isoform expression levels of isocitrate dehydrogenase in breast cancer: IDH2 is a potential target in MDA-MB-231 cells
    Shuyu Piao et al, 2023, Korean J Clin Oncol CrossRef
25. Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway
    Shixiong Liu et al, 2024, International Immunopharmacology CrossRef
26. The expression of DNAJB9 in normal human astrocytes is more sensitive to nanographene oxide than in glioblastoma cells
    Oleksandr Minchenko et al, 2024 CrossRef